We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Boehringer Ingelheim RCV provides over six million patients with innovative therapies. Ensuring that the patients’ needs at every stage are met precisely is of decisive importance.
At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Wir sehen es als unsere Pflicht an, bestmöglich für den Schutz und die Gesundheit unserer Mitarbeitenden, unserer Patienten und der Gesellschaft Sorge zu tragen. Um die globale Ausbreitung von COVID-19 einzudämmen und zu bewältigen, ist Boehringer Ingelhe
Find out how you can keep your feline companion happy and healthy. 10 important questions about cat vaccination to help you make informed decisions about maintaining your cat’s health.
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.